TY  - JOUR 
AU  - Hernández Goenaga, Juan
AU  - López Abán, Julio
AU  - Protasio, Anna V.
AU  - Vicente Santiago, María Belén
AU  - Olmo Fernández, Esther del
AU  - Vanegas, Magnolia
AU  - Fernández Soto, Pedro
AU  - Patarroyo Gutiérrez, Manuel Alfonso
AU  - Muro Álvarez, Antonio
AU  - Hernández-Goenaga, Juan
AU  - López-Abán, Julio
AU  - Vicente Santiago, Belén
AU  - del Olmo, Esther
AU  - Fernández-Soto, Pedro
AU  - Patarroyo, Manuel Alfonso
AU  - Muro, Antonio
PY  - 2019
UR  - http://hdl.handle.net/10366/162135
AB  - [EN] Schistosomiasis is a significant public health problem in sub-Saharan Africa, China,
Southeast Asia, and regions of South and Central America affecting about 189 million
people. Kunitz-type serine protease inhibitors have been identified as...
LA  - eng
PB  - Frontiers Media
KW  - Schistosoma mansoni
KW  - helminth vaccines
KW  - kunitz-type proteins
KW  - synthetic peptide
KW  - immunomodulator AA0029
KW  - ADAD vaccination system
KW  - Schistosoma
KW  - Vaccines
TI  - Peptides Derived of Kunitz-Type Serine Protease Inhibitor as Potential Vaccine Against Experimental Schistosomiasis
DO  - 10.3389/fimmu.2019.02498
T2  - Frontiers in Immunology
VL  - 10
M2  - 1
ER  -